What do you want me to tell you? Tell you that this will be $50 after approval? That calling Cramer is a great idea? Do you even follow Cramer's track record to understand how he operates?
Listen, I've been in this street game long enough to understand the landscape. But here on ETRM, all ever see is more amateurish-gibberish jazz on both sides. There is little educational factor as well and zero pinch of realism.
Between Ade and Oozhee, whom I think are equally crazy, somewhere in the middle lies the eventual outcome. I bought this knowing this is a device to help with obesity not therapeutics to cure cancer. So I've invested in it and set your expectations accordingly.
Sorry for not being emotionally involved, dude.
Hey, I voted this down. I'm not sure why 9 people are eating your posts. I'm tired of reading Ade's novel about his shares at every hour of the day. If you're a true investor and you got in early on CSIQ and KERX, then you would know to just sit and lay low.
As a matter of fact, almost every stock has doubled since 2012. Solar stocks especially. So picking CSIQ is far from making you a genius. Furthermore, if you actually got in early at all those names that you've posted, you would not spend all your days here trying to pump an $85m company. So please cut the b-s narratives and learn to lay low without pointing fingers at your past history.
You're kidding, right? Because of one stock you are seriously praying for Obamacare to cover obesity device at $25k per patient just so you could make shhh loads of money? You are kidding, right?
"People are obese because they are lazy and undisciplined. "
Let me respond to that statement;
Several studies have found that tendency for obesity is inversely proportional to income. The lower your income, the more likely you're obese. Therefore, you can find correlation between obesity and socioeconomic factors.
Consequently, we can conclude that low income individuals are most likely to be going be obese. Which then brings us to addressable market. For $25k that has been mentioned as cost of surgery and device, you are looking at hefty fee for those with already low income. Many would rather live with their weight as they always have. Very few would have a life threatening event to make them consider weight lose device.
Additionally, a patient with low income is less likely to get coverage for VBLOC under their insurance.
Again, I'm not questioning the device or its science, but I am absolutely questioning some of the numbers that have been thrown out there. Those numbers are absolutely baseless.
I am totally with you, Rodtross. You say what many don't ever want to hear. At $1.24, if FDA approves tomorrow, $2 would appear to as though it is a huge return without factoring in how this stock continues to slide on the face of multiple good news. And for those predicting x5 current price, KERX was the same last week. And this week we have OREX. Every LONG thought they had hit a home run.
Given the cost of VBLOC, I think only extremely obese people with deep pocket would even consider it. Meaning the addressable market is not the rosy picture everyone has been painting it to be. Someone said on CNBC just this morning.. You can't beat exercise when it comes to weight lose. That is exactly why I think VBLOC holds little value in Europe and Australia where there is greater emphasis on healthy living. Anyone that has been to mainland Europe and Australia would know this as a fact and Americans are now also learning. There are now healthy living options all around the country than ever before.
In close, I'm a realist. If FDA approves, I believe that the upside would be limited based on actual addressable market. Anyone that is expecting a $1bn company from this is living inside their head and not reality of the market.
How's that OREX working out for you, Oozhee?
You're an idiot! Even though I understand that the FDA game is not always a guarantee to the upside, you make it easy to ridicule you for your constant bashing.
I have money parked in ETRM strictly as a speculative play. Biotech is full of so much shhhshow that you can't always expect ridiculous returns. DSCO is an example of that. Got approved, it spiked to over $5 from mid $3, and with few hours, management fcked shareholders over by announcing an offering. This was three years ago and that stock has never recovered since. Last week was KERX's turn. Everyone was banking on 100% rise upon approval but it has since lost over 20% of the week's high.
Fact is that approval is not always the be all especially if management fail to convince the street. However, ETRM has one great thing going for it.. low float and low market cap! If approved, that gives it better chance of hefty returns. That is worth the risk as we continue to watch the lame daily price movement. But nothing is guaranteed in this space.
LOOL. Stupid people! They would shell money out for shhh that is already widely available on the market at discount.
I just saw the volume for today and I busted out laughing. I'm not even sure why I found it funny. Maybe because I know that ETRM is manipulated as hell.
No point even following the daily price movement in my opinion. Just chill out until FDA and don't use margins.
I don't actually understand how anyone can vote 'No' on Efficacy and then 'Yes' on Benefits vs Risk. I would respect a No, No on both or a Yes on efficacy but No on Benefits vs Risk. It really shows how subjective the whole voting process is and why safety is really the most important benchmark.
He obviously has vested invest in the stock. However, it has nothing to do with any listed company. That is the kind of security and corruption crime that could bring down a company hard. Medtronic would not be that stupid to risk it all over a tiny cap company.
He is most likely working for some small time money manager with couple of hundreds of thousands of dollars to manipulate price movement. Given the low PPS and float, ETRM is very easy to manipulate.
Regardless, Oozhee is a lying poster that should simply be ignored.
So you have no position in a stock that has less than $100m market cap, yet you spend your time writing articles to bash it.
I don't give a shhh if you're SA Pro or SA clown, spending time researching something you have absolutely zero vested interest in makes you just another loser on SA that would write shh for the clicks.
Furthermore, being on SA PRO does not actually make your opinion factual.. Even analysts on CNBC would never dare say their opinion carries more weight than the next person. So please, drop the SA PRO b-s!
Lastly, your comment about being on wrong side of the debate is simply amateurish. This is a stock that is still waiting on approval and trades mostly on poor volume and low float. How can you say anyone is on the wrong or right side of the debate when the fate has yet to be decided?